المؤلفون: P Sonneveld, A Chanan-Khan, K Weisel, AK Nooka, T Masszi, M Beksac, I Spicka, V Hungria, M Munder, MV Mateos, TM Mark, MD Levin, T Ahmadi, X Qin, W Garvin Mayo, X Gai, J Carey, R Carson, A Spencer

المصدر: HemaSphere, Vol 6, Pp 12-12 (2022)

مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: http://journals.lww.com/10.1097/01.HS9.0000829588.31575.a9; https://doaj.org/toc/2572-9241

URL الوصول: https://doaj.org/article/accd84a847664b2e877ffc158d3a69df

المؤلفون: AK Nooka, LJ Costa, CJ Gasparetto, PG Richardson, DS Siegel, A Chari, S Lentzsch, S Jagannath, J. Mikhael

المصدر: Clinical Lymphoma Myeloma and Leukemia. 22:e526-e531

مصطلحات موضوعية: Adult, Cancer Research, Consensus, Hydrazines, Oncology, Antineoplastic Combined Chemotherapy Protocols, Humans, Hematology, Triazoles, Multiple Myeloma, Dexamethasone

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0e4f154fc17c0bdb11485b4653167d7
https://doi.org/10.1016/j.clml.2022.01.014

المؤلفون: Nooka AK; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA., Kaufman JL; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA., Rodriguez C; Icahn School of Medicine at Mount Sinai, New York, New York, USA., Jakubowiak A; University of Chicago Medical Center, Chicago, Illinois, USA., Efebera Y; OhioHealth, Columbus, Ohio, USA., Reeves B; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Wildes TM; Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA., Holstein SA; Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA., Anderson LD Jr; Myeloma, Waldenström's and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas, USA., Badros A; Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, Maryland, USA., Shune L; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA., Chari A; Icahn School of Medicine at Mount Sinai, New York, New York, USA.; University of California at San Francisco, San Francisco, California, USA., Pei H; Janssen Research & Development, LLC, Titusville, New Jersey, USA., Cortoos A; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, USA., Patel S; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, USA., Lin TS; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, USA., Voorhees PM; Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, North Carolina, USA., Usmani SZ; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Richardson PG; Dana-Farber/Partners Cancer Care, Boston, Massachusetts, USA.

المصدر: British journal of haematology [Br J Haematol] 2024 Jun; Vol. 204 (6), pp. 2227-2232. Date of Electronic Publication: 2024 Mar 19.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Lenalidomide*/administration & dosage , Lenalidomide*/adverse effects , Lenalidomide*/therapeutic use , Dexamethasone*/administration & dosage , Dexamethasone*/adverse effects , Dexamethasone*/therapeutic use , Bortezomib*/administration & dosage , Bortezomib*/adverse effects , Bortezomib*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/administration & dosage , Multiple Myeloma*/drug therapy , Antibodies, Monoclonal*/administration & dosage , Antibodies, Monoclonal*/adverse effects , Antibodies, Monoclonal*/therapeutic use, Humans ; Female ; Male ; Middle Aged ; Aged ; Adult ; Black or African American

المؤلفون: Ludwig H; Wilhelminen Cancer Research Institute, Vienna, Austria., Munshi NC; Dana Farber Cancer Institute, Boston, Massachusetts, United States., Terpos E; National and Kapodistrian University of Athens, School of Medicine, Athens, Greece., Schweitzer I; Wilhelminen Cancer Research Institute, Vienna, Austria., Raje N; Massachusetts General Hospital, Boston, Massachusetts, United States., Moreau P; Hematology, University Hospital Hôtel-Dieu, Nantes, France., Nooka AK; Emory University Winship Cancer Institute, Atlanta, Georgia, United States.

المصدر: Blood advances [Blood Adv] 2024 May 22. Date of Electronic Publication: 2024 May 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

المؤلفون: Wheeler AP; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN., Snyder EL; Laboratory Medicine, Transfusion Service, Yale University School of Medicine, New Haven, CT., Refaai M; Transfusion Service, University of Rochester Medical Center, Rochester, NY., Cohn CS; Blood Bank Laboratory, University of Minnesota Medical Center, Minneapolis, MN., Poisson J; Department of Pathology, Duke University Medical Center, Durham, NC., Fontaine M; Transfusion Service, University of Maryland Medical Center, Baltimore, MD., Sehl M; Hematology Oncology, UCLA Medical Center, Los Angeles, CA., Nooka AK; Hematology Oncology, Emory University Medical Center, Atlanta, GA., Uhl L; Laboratory and Transfusion Medicine, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA., Spinella PC; Surgery and Critical Care, University of Pittsburgh Medical Center, Pittsburgh, PA., Fenelus M; Pathology, Clinical Laboratory, Memorial-Sloan Kettering Medical Center, New York, NY., Liles D; Hematology Oncology, East Carolina University Medical Center, Greenville, NC., Coyle T; Oncology, TriHealth Medical Center, Cincinnati, OH., Becker J; Pathology, Transfusion Medicine, Roswell Park Medical Center, Buffalo, NY., Jeng M; Pediatric Hematology Oncology, Stanford University School of Medicine, Palo Alto, CA., Gehrie EA; Transfusion Medicine, Johns Hopkins Medical Institute, Baltimore, MD., Spencer BR; American Red Cross Scientific Affairs, Dedham, MA., Young P; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN., Johnson A; Blood Bank Laboratory, University of Minnesota Medical Center, Minneapolis, MN., O'Brien JJ; Transfusion Medicine, Mayo Clinic Florida, Jacksonville, FL., Schiller GJ; Hematology Oncology, Ronald Reagan UCLA Medical Center, David Geffen School of Medicine, Los Angeles, CA., Roback JD; Hematology Oncology, Emory University Medical Center, Atlanta, GA., Malynn E; Laboratory and Transfusion Medicine, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA., Jackups R; Department of Pathology, Washington University St. Louis, St. Louis, MO., Avecilla ST; Pathology, Clinical Laboratory, Memorial-Sloan Kettering Medical Center, New York, NY., Liu K; Scientific Affairs, Cerus Corporation, Concord, CA., Bentow S; Scientific Affairs, Cerus Corporation, Concord, CA., Varrone J; Scientific Affairs, Cerus Corporation, Concord, CA., Benjamin RJ; Scientific Affairs, Cerus Corporation, Concord, CA., Corash LM; Scientific Affairs, Cerus Corporation, Concord, CA.

المصدر: Blood advances [Blood Adv] 2024 May 14; Vol. 8 (9), pp. 2290-2299.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Platelet Transfusion*/adverse effects, Humans ; Female ; Middle Aged ; Male ; Aged ; Acute Lung Injury/etiology ; Blood Platelets ; Prospective Studies ; Adult ; Thrombocytopenia/etiology ; Hematologic Diseases/therapy

المؤلفون: Barberio J; Department of Epidemiology, Emory University, Atlanta, Georgia, USA.; Center for Observational Research, Amgen Inc., Thousand Oaks, California, USA., Lash TL; Department of Epidemiology, Emory University, Atlanta, Georgia, USA., Nooka AK; Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA., Naimi AI; Department of Epidemiology, Emory University, Atlanta, Georgia, USA., Patzer RE; Department of Epidemiology, Emory University, Atlanta, Georgia, USA.; Regenstrief Institute, Indianapolis, Indiana, USA., Kim C; Center for Observational Research, Amgen Inc., Thousand Oaks, California, USA.

المصدر: Acta haematologica [Acta Haematol] 2024 May 10, pp. 1. Date of Electronic Publication: 2024 May 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Karger Country of Publication: Switzerland NLM ID: 0141053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1421-9662 (Electronic) Linking ISSN: 00015792 NLM ISO Abbreviation: Acta Haematol Subsets: MEDLINE

المؤلفون: Rodriguez-Otero P; Cancer Center Clinica Universidad de Navarra, CCUN, Cima, IDISNA, CIBERONC, Spain. Electronic address: paurodriguez@unav.es., Usmani S; Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA., Cohen AD; University of Pennsylvania, Philadelphia, Pennsylvania, PA, USA., van de Donk NWCJ; Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Leleu X; Centre Hospitalier Universitaire Poitiers, Poitiers, France., Gállego Pérez-Larraya J; Department of Neurology, Clínica Universidad de Navarra, Cancer Center Clinica Universidad de Navarra, CCUN, Pamplona, Spain., Manier S; Centre Hospitalier Universitaire Lille, Universite de Lille, Lille, France., Nooka AK; Department of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory University, Atlanta, GA, USA., Mateos MV; University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain., Einsele H; Universitätsklinikum Würzburg, Department of Internal Medicine II, Würzburg, Germany., Minnema M; Department of Hematology, University Medical Center, Utrecht, Netherlands., Cavo M; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy; Dipartimento di Scieze Mediche e Chirurgiche, Universitá di Bologna, Bologna, Italy., Derman BA; Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., Puig N; University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain., Gay F; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino, Italy., Ho PJ; Royal Prince Alfred Hospital and University of Sydney, Sydney, NSW, Australia., Chng WJ; Department of Hematology-Oncology, National University Cancer Institute, Singapore., Kastritis E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Gahrton G; Department of Medicine, Karolinska Institutet, Huddinge, Stockholm, Sweden., Weisel K; Universitätsklinikum Hamburg-Eppendorf, Medizinische Klinik und Poliklinik, Hamburg, Germany., Nagarajan C; Department of Haematology, Singapore General Hospital and SingHealth Duke NUS Blood Cancer Center, Singapore., Schjesvold F; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway; KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway., Mikhael J; Translational Genomics Research Institute, City of Hope Cancer Center, Phoenix, AZ, USA; International Myeloma Foundation, Studio City, CA, USA., Costa L; Department of Medicine, Division of Hematology and Oncology, University of Wisconsin, Madison, WI, USA., Raje NS; Department of Medical Oncology, Massachusetts General Hospital, Boston, MA, USA., Zamagni E; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy; Dipartimento di Scieze Mediche e Chirurgiche, Universitá di Bologna, Bologna, Italy., Hájek R; Department of Hemato-oncology, University Hospital Ostrava, Ostrava, Czech Republic., Weinhold N; Department of Medicine V, Multiple Myeloma Section, University Hospital Heidelberg, Heidelberg, Germany., Yong K; University College London Hospitals, London, UK., Ye JC; MD Anderson Cancer Center, University of Texas, Houston, TX, USA., Sidhana S; Stanford University School of Medicine, Stanford, CA, USA., Merlini G; Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Martin T; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., Lin Y; Mayo Clinic, Rochester, MN, USA., Chari A; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., Popat R; NIHR UCLH Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, UK., Kaufman JL; Department of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory University, Atlanta, GA, USA.

مؤلفون مشاركون: International Myeloma Working Group

المصدر: The Lancet. Oncology [Lancet Oncol] 2024 May; Vol. 25 (5), pp. e205-e216.

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't; Practice Guideline

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Bispecific*/therapeutic use , Multiple Myeloma*/immunology , Multiple Myeloma*/therapy , Multiple Myeloma*/drug therapy , Consensus* , T-Lymphocytes*/immunology , T-Lymphocytes*/drug effects, Humans ; Immunotherapy/methods ; Immunotherapy/standards ; Antineoplastic Agents, Immunological/therapeutic use ; Antineoplastic Agents, Immunological/adverse effects

المؤلفون: Mohty M; Sorbonne University, Hôpital Saint-Antoine, and INSERM UMRS 938, Paris, France., Bahlis NJ; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., Nooka AK; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA., DiBonaventura M; Pfizer Inc, New York, New York, USA., Ren J; Pfizer Inc, Collegeville, Pennsylvania, USA., Conte U; Pfizer Inc, New York, New York, USA.

المصدر: British journal of haematology [Br J Haematol] 2024 May; Vol. 204 (5), pp. 1801-1810. Date of Electronic Publication: 2024 Feb 29.

نوع المنشور: Clinical Trial; Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/drug therapy , Multiple Myeloma*/psychology , Patient Reported Outcome Measures* , Quality of Life*, Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Antibodies, Bispecific/therapeutic use ; Antibodies, Bispecific/administration & dosage ; Antibodies, Monoclonal, Humanized/therapeutic use ; B-Cell Maturation Antigen

المؤلفون: Rodriguez-Otero P; Clínica Universidad de Navarra, Pamplona, Spain., Ailawadhi S; Mayo Clinic, Jacksonville, FL, USA., Arnulf B; Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France., Patel K; M.D. Anderson Cancer Center, University of Texas, Houston, TX, USA., Cavo M; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Seràgnoli Institute of Hematology, & the Department of Experimental, Diagnostic, & Specialty Medicine, Bologna University School of Medicine, Bologna, Italy., Nooka AK; Winship Cancer Institute of Emory University, Atlanta, GA, USA., Manier S; Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France., Callander N; University of Wisconsin Carbone Cancer Center, Madison, WI, USA., Costa LJ; University of Alabama at Birmingham, Birmingham, AL, USA., Vij R; Washington University School of Medicine in St. Louis, St. Louis, MO, USA., Bahlis NJ; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Moreau P; University Hospital of Nantes, Nantes, France., Solomon SR; Northside Hospital Cancer Institute, Atlanta, GA, USA., Delforge M; Universitaire Ziekenhuizen Leuven, Leuven, Belgium., Berdeja J; Sarah Cannon Research Institute & Tennessee Oncology, Nashville, TN, USA., Truppel-Hartmann A; 2seventy bio, Cambridge, MA, USA., Yang Z; Bristol Myers Squibb, Princeton, NJ, USA., Favre-Kontula L; Bristol Myers Squibb, Princeton, NJ, USA., Wu F; Bristol Myers Squibb, Princeton, NJ, USA., Piasecki J; Bristol Myers Squibb, Princeton, NJ, USA., Cook M; Bristol Myers Squibb, Princeton, NJ, USA.; Institute of Cancer & Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Giralt S; Memorial Sloan Kettering Cancer Center, New York, NY, USA.

المصدر: Future oncology (London, England) [Future Oncol] 2024 Apr 23, pp. 1-15. Date of Electronic Publication: 2024 Apr 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

المؤلفون: Suvannasankha A; Indiana University Simon Cancer Center and Roudebush VAMC, Indianapolis, Indiana, USA., Bahlis N; Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, Alberta, Canada., Trudel S; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Weisel K; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Koenecke C; Hannover Medical School, Clinic for Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover, Germany., Oriol A; Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain., Voorhees PM; Levine Cancer Institute, Atrium Health/Wake Forest University School of Medicine, Charlotte, North Carolina, USA., Alonso AA; Hospital Universitario Quirónsalud Madrid, Madrid, Spain., Callander NS; Carbone Cancer Center, University of Wisconsin, Madison, Wisconsin, USA., Mateos MV; Instituto de Investigación Biomédica de Salamanca and Centro de Investigación del Cáncer, Hospital Universitario de Salamanca, Salamanca, Spain., Reddy N; Merck & Co., Inc, Rahway, New Jersey, USA., Hakim S; GlaxoSmithKline, Upper Providence, Pennsylvania, USA., LaMacchia J; GlaxoSmithKline, Waltham, Massachusetts, USA., Patel N; GlaxoSmithKline, Stevenage, UK., Williams D; GlaxoSmithKline, Upper Providence, Pennsylvania, USA., Jewell RC; GlaxoSmithKline, Durham, North Carolina, USA., Zhou X; GlaxoSmithKline, Upper Providence, Pennsylvania, USA., Gupta I; GlaxoSmithKline, Philadelphia, Pennsylvania, USA., Opalinska J; GlaxoSmithKline, Upper Providence, Pennsylvania, USA., Nooka AK; Winship Cancer Institute, Emory University Hospital, Atlanta, Georgia, USA.

المصدر: Cancer [Cancer] 2024 Apr 17. Date of Electronic Publication: 2024 Apr 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE